Skip to main content

Advertisement

Log in

Correlation between the current TNM staging and long-term survival after curative D1 lymphadenectomy for stomach cancer

  • Original Article
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Background and aims

This study aims to assess the tumour-related factors that influence long-term survival after curative gastrectomy with standard D1 lymphadenectomy for patients with stomach cancer.

Patients and methods

Patients who had undergone curative gastrectomy for carcinoma of the stomach at North Shore Hospital between 1990 and 2000 were identified from theatre records and the hospital database. Medical records were reviewed and included tumour location, type of operation, in-hospital mortality, gross morphology of tumour, histological type, and Helicobacter status; pathology slides were reviewed, and tumours were staged according to the new TNM staging. Patients were followed-up for 2–11 years. Length of survival was obtained for each patient from medical records or from family doctors.

Results

R0 gastrectomy was performed on 70 patients; median survival was 23 months, and all patients with early gastric cancer are currently still alive. T stage, nodal stage and histological type correlated significantly with survival, but multivariate analysis showed that T stage is the most significant predictor. Five-year survival was 26%. Significant survival difference was seen between T2a and T2b.

Conclusion

Histological subtype, lymph node metastases and depth of invasion are factors that affect survival of patients with gastric cancer; however, depth of invasion is more important than other variables. Tumour location and type of gastrectomy has no effect on survival. The latest TNM classification (sixth edition) gives a better prognostication than the previous classification.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Pacelli FPC, Sgadari A, Bossola M, Doglietto GB (2001) Proximal compared with distal gastric cancer: multivariate analysis of prognostic factors. Am Surg 67:697–703

    CAS  PubMed  Google Scholar 

  2. Parsonnet JRH, Hack HM, Owens DK (1996) Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet 348:150–154

    CAS  PubMed  Google Scholar 

  3. Katsube TKO, Hamaguchi K, Murayama M, et al (2002) Prevalence of Helicobacter pylori in the residual stomach after gastrectomy for gastric cancer. Hepatogastroenterology 49:128–132

    PubMed  Google Scholar 

  4. Roviello F, Marrelli D, Morgagni P, de Manzoni G, Di Leo A, Vindigni C, Saragoni L, Tomezzoli A, Kurihara H, Italian Research Group for Gastric Cancer (2002) Benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: a longitudinal multicenter study. Ann Surg Oncol 9:894–900

    PubMed  Google Scholar 

  5. Inoue KYN, Michiura T, Kakai N, et al (2002) Histopathological grading does not affect survival after R0 surgery for gastric cancer. Eur J Surg Oncol 28:633–636

    CAS  PubMed  Google Scholar 

  6. Reis ENK, Doganay M (2002) Long-term survival is improved by an extended lymph node dissection in potentially curable gastric cancer. Hepatogastroenterology 49:1167–1171

    PubMed  Google Scholar 

  7. Hyung JL, Choi SH, Min JS, Noh SH (2002) Prognostic impact of lymphatic and/or blood vessel invasion in patients with node-negative advanced gastric cancer. Ann Surg Oncol 9:562–567

    PubMed  Google Scholar 

  8. Yasuda KYA, Shiraishi N, Inomata M, Takeuchi H, Kitano S (2002) Prognostic effect of lymph node micrometastasis in patients with histologically node-negative gastric cancer. Ann Surg Oncol 9:771–774

    Article  PubMed  Google Scholar 

  9. Kajtani T, Japanese Research Society for the Study of Gastric Cancer (1981) The general rules for gastric cancer study in surgery and pathology. Jpn J Surg 11:127–145

    PubMed  Google Scholar 

  10. Jahne JPP, Meyer HJ (2001) 1,114 total gastrectomies in the surgical treatment of primary gastric adenocarcinoma—a 30-year single institution experience. Hepatogastroenterology 48:1222–1226

    CAS  PubMed  Google Scholar 

  11. Cuschieri AIT, Weeden S (2002) Influence of pathological tumour variables on long-term survival in resectable gastric cancer. Br J Cancer 86:674–679

    CAS  PubMed  Google Scholar 

  12. Martin DJ, Brennan MF, Karpeh M (2002) Extended local resection for advanced gastric cancer: increased survival versus increased morbidity. Ann Surg 236:159–165

    PubMed  Google Scholar 

  13. D’Ugo DFP, Persiani R (2002) Impact of the latest TNM classification for gastric cancer: retrospective analysis on 94 D2 gastrectomies. World J Surg 26:672–677

    PubMed  Google Scholar 

  14. Bouvier OH, Piard F, Roignot P, Bonithon-Kopp C, Faivre J (2002) How many nodes must be examined to accurately stage gastric carcinomas? Results from a population based study. Cancer 94:2862–2866

    PubMed  Google Scholar 

  15. Lee HY, Kim WH, Lee KU, Choe KJ, Kim JP (2002) Influence of the number of lymph nodes examined on staging of gastric cancer. Br J Surg 8:1408–1412

    Google Scholar 

  16. Karpeh M, Brennan MF (2000) Lymph node staging in gastric cancer: is location more important than number? An analysis of 1,038 patients. Ann Surg 232:362–371

    CAS  PubMed  Google Scholar 

  17. Bonenkamp JJ, Songun I, Hermans J, Sasako M, et al (1995) Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Multicenter study. Randomized controlled trial. Lancet 345:745–748

    Article  CAS  PubMed  Google Scholar 

  18. Ramacciato FDA, Cicchini C, Sternberg CN (2000) Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection? Hepatogastroenterology 47:1470–1474

    CAS  PubMed  Google Scholar 

  19. Hartgrink HH, Van de Velde CJH, Putter H, et al (2004) Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomised Dutch gastric cancer group trial. J Clin Oncol 22:2069–2077

    CAS  PubMed  Google Scholar 

  20. Nogueira AS, Santos JN, Silva AG, Ferreira J, Matos E, Vilaca H (2002) Early gastric cancer: ten years of experience. World J Surg 26:330–334

    PubMed  Google Scholar 

  21. Popiela JK, Kolodziejczyk P, Sierzega M (2002) Long-term results of surgery for early gastric cancer. Br J Surg 89:1035–1042

    CAS  PubMed  Google Scholar 

  22. Abe TW, Suzuki K, Machida H, et al (2002) Risk factors predictive of lymph node metastasis in depressed early gastric cancer. Am J Surg 183:168–172

    PubMed  Google Scholar 

  23. Kabashima YM, Sugimachi K (2001) Overexpression of vascular endothelial growth factor C is related to lymphogenous metastasis in early gastric carcinoma. Oncology 60:146–150

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Saleh M. Abbas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abbas, S.M., Booth, M.W. Correlation between the current TNM staging and long-term survival after curative D1 lymphadenectomy for stomach cancer. Langenbecks Arch Surg 390, 294–299 (2005). https://doi.org/10.1007/s00423-004-0527-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-004-0527-2

Keywords

Navigation